Материалов:
1 005 012

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 91372

Страница 3 из 9138

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from RussiaAd5-S). We aimed to assess the safety and immunogenicity of two formulations (frozen and lyophilised

Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine with A(H5N2) LAIV induced a long-lasting B-cell immunological memory against influenza A(H5N1) virus

Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets-LAIVs against challenge with homologous and heterologous wild-type (WT) influenza B viruses. Methods. Groups

Comparative immunological study in mice of inactivated influenza vaccines used in the Russian immunization program methods for quantifying immune response, such as hemagglutination inhibition (HAI) assay and virus

Current trends in diagnostics of viral infections of unknown etiologyViruses are evolving at an alarming rate, spreading and inconspicuously adapting to cutting

Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model274Y NA mutation affects the fitness of two H5N1 influenza viruses differently. Our novel method

Cloning, expression, and purification of the nucleocapsid protein of SARS coronavirusvirus protein

OVERVIEW OF THE MAIN TRENDS IN THE ECONOMIC ASSESSMENT OF ECOSYSTEM SERVICES assessment of ecosystem services was conducted, a classification of ES and economic methods was provided

Non-neutralizing antibodies directed at conservative influenza antigens antibodies, including non-neutralizing ones, as well as to be in the possession of methods for quantifying

Immunogenicity and safety of a trivalent subunit immunoadjuvant influenza vaccine in children with type 1 diabetes: Results of a prospective comparative study: Our aim was to assess immunogenicity and safety of a trivalent subunit immunoadjuvant influenza

Страница 3 из 9138